Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 11, Pages 3421-3426
Publisher
Proceedings of the National Academy of Sciences
Online
2015-03-04
DOI
10.1073/pnas.1414573112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcriptional and posttranslational regulation of insulin-like growth factor binding protein-3 by Akt3
- (2014) Quanri Jin et al. CARCINOGENESIS
- AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2+ breast tumor cells from Balb-neuT mice
- (2014) Nicole Grabinski et al. CELLULAR SIGNALLING
- Phosphoproteomics Screen Reveals Akt Isoform-Specific Signals Linking RNA Processing to Lung Cancer
- (2014) Ioannis Sanidas et al. MOLECULAR CELL
- Role of AKT signaling in DNA repair and clinical response to cancer therapy
- (2014) Q. Liu et al. NEURO-ONCOLOGY
- High-grade gliomas: reality and hopes
- (2014) Rene-Olivier Mirimanoff Chinese Journal of Cancer
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- AKT3 controls mitochondrial biogenesis and autophagy via regulation of the major nuclear export protein CRM-1
- (2013) Daniel G. Corum et al. FASEB JOURNAL
- Investigation of molecular alterations ofAKT-3in triple-negative breast cancer
- (2013) Gillian O'Hurley et al. HISTOPATHOLOGY
- Akt-Mediated Phosphorylation of Argonaute 2 Downregulates Cleavage and Upregulates Translational Repression of MicroRNA Targets
- (2013) Shane R. Horman et al. MOLECULAR CELL
- Targeting the PI3K-AKT-mTOR signaling network in cancer
- (2013) Khurum H. Khan et al. Chinese Journal of Cancer
- The ATM protein: The importance of being active: Figure 1.
- (2012) Yosef Shiloh et al. JOURNAL OF CELL BIOLOGY
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF- B network
- (2012) K. M. Holmes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nonredundant Functions for Akt Isoforms in Astrocyte Growth and Gliomagenesis in an Orthotopic Transplantation Model
- (2011) R. Endersby et al. CANCER RESEARCH
- The Akt kinases: Isoform specificity in metabolism and cancer
- (2011) Eva Gonzalez et al. CELL CYCLE
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Akt2 and Akt3 play a pivotal role in malignant gliomas
- (2011) H. Mure et al. NEURO-ONCOLOGY
- Akt2 interacts with Snail1 in the E-cadherin promoter
- (2011) P Villagrasa et al. ONCOGENE
- Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma
- (2010) Hiroyuki Michiue et al. CANCER BIOLOGY & THERAPY
- Akt3-Mediated Resistance to Apoptosis in B-RAF-Targeted Melanoma Cells
- (2010) Y. Shao et al. CANCER RESEARCH
- Distinct Biological Roles for the Akt Family in Mammary Tumor Progression: Figure 1.
- (2010) Rachelle L. Dillon et al. CANCER RESEARCH
- The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration
- (2010) Y. Rebecca Chin et al. MOLECULAR CELL
- IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas
- (2009) L. M. Moore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells
- (2009) D. Iliopoulos et al. Science Signaling
- Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
- (2008) M. Cheung et al. CANCER RESEARCH
- Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery
- (2008) Lu-Hai Wang et al. CURRENT CANCER DRUG TARGETS
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search